| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Fabian, ID, et al.
(författare)
-
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries
- 2021
-
Ingår i: The British journal of ophthalmology. - : BMJ. - 1468-2079 .- 0007-1161. ; 105:10, s. 1435-1443
-
Tidskriftsartikel (refereegranskat)abstract
- The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe.MethodsA cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries.ResultsCapture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI −12.4 to −5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease.ConclusionsFewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
- Rodrigues, Camila, et al.
(författare)
-
Comparison of Intramuscular and Surface Electromyography Recordings towards the Control of Wearable Robots for Incomplete Spinal Cord Injury Rehabilitation
- 2020
-
Ingår i: Proceedings of the IEEE RAS and EMBS International Conference on Biomedical Robotics and Biomechatronics. - 2155-1774. ; 2020-November, s. 564-569
-
Konferensbidrag (refereegranskat)abstract
- Spinal Cord Injury (SCI) affects thousands of people worldwide every year. SCI patients have disrupted muscle recruitment and are more predisposed to other complications. To recover or enhance lower limbs functions, conventional rehabilitation programs are typically used. More recently, conventional programs have been combined with robot-assisted training. Electromyography (EMG) activity is generally used to record the electrical activity of the muscles, which in turn can be used to control robotic assistive devices as orthoses, prostheses and exoskeletons. In this sense, surface EMG can be used as input to myoelectric control but presents some limitations such as myoelectric crosstalk, as well as the influence of motion artefacts, and electromagnetic noise. EMG can also be recorded using intramuscular detection systems, which allows the detection of electric potentials closer to the muscle fibres and the recording of EMG activity from deeper muscles. This paper evaluates the quality of intramuscular EMG recordings compared to surface EMG signals, as a preliminary step to control EMG-driven exoskeletons. Seven healthy subjects performed submaximal knee and ankle flexion/extension movements with and without the use of a lower limb exoskeleton. Intramuscular recordings presented early muscle activation detecting times, which is a very important feature in real-time control, and good signal-to-noise ratio values, showing the potential of these biosignals as reliable input measures to control exoskeletons for rehabilitation purposes.
|
|
